Women's Pattern Hair Loss: Why It's Completely Different From Male AGA
Female pattern hair loss — androgenetic alopecia in women — affects around 40% of women by age 50. It is dramatically underdiagnosed, poorly discussed, and routinely misunderstood because its presentation is nothing like the male pattern most people picture. Here's what women experiencing it actually need to know.
01How it presents differently than in men
Male AGA follows the Norwood stages — recession at the temples, crown thinning, eventual baldness. Female AGA follows the Ludwig scale — diffuse thinning across the top and crown, with the frontal hairline typically preserved. Women rarely go completely bald; instead they experience progressive overall density reduction that widens the part and reduces the appearance of volume. The look is "thinning" rather than "bald," which often delays diagnosis because the change is gradual and diffuse.
Because female hair loss doesn't look like male hair loss, women often go years without a correct diagnosis — cycling through thyroid tests, iron checks, and dietary experiments while the real culprit (androgenetic alopecia) goes untreated. The earlier the correct diagnosis, the better the treatment response.
02The causes are the same but the hormonal picture is more complex
DHT (dihydrotestosterone) drives follicle miniaturization in women just as it does in men. But women have additional hormonal layers — estrogen, progesterone, DHEA, thyroid — that interact with androgen activity. Hair loss can begin or accelerate at hormonal transition points: puberty, pregnancy, postpartum, perimenopause, and menopause. This is why a complete female hair loss evaluation includes hormone panels, not just a dermatology visit.
03Treatment options for women
- Minoxidil (topical or oral): FDA-approved for women — the 2% concentration is labeled for women, though 5% and low-dose oral are widely used off-label with good evidence. First-line treatment.
- Spironolactone: an anti-androgen used off-label for female AGA. Widely prescribed for women with hormonal-driven hair loss; reduces androgen activity more safely in women than men.
- Finasteride: not first-line for women and contraindicated in pregnancy — but used off-label in post-menopausal women in some cases. Requires specific clinical discussion.
- Hormone optimization: for perimenopausal or menopausal women, estrogen and progesterone changes can be part of the picture — worth discussing with a gynecological endocrinologist.
Get a provider who understands female pattern loss
Telehealth evaluation — female hair loss workup
Paid link Book a visit →Provider consult for women's hair loss treatment
Paid link Start your plan →